396 related articles for article (PubMed ID: 11970879)
1. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity.
Kasaian MT; Whitters MJ; Carter LL; Lowe LD; Jussif JM; Deng B; Johnson KA; Witek JS; Senices M; Konz RF; Wurster AL; Donaldson DD; Collins M; Young DA; Grusby MJ
Immunity; 2002 Apr; 16(4):559-69. PubMed ID: 11970879
[TBL] [Abstract][Full Text] [Related]
2. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
3. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.
Dhanji S; Teh HS
J Immunol; 2003 Oct; 171(7):3442-50. PubMed ID: 14500639
[TBL] [Abstract][Full Text] [Related]
4. IL-21 and IL-21 receptor: a new cytokine pathway modulates innate and adaptive immunity.
Collins M; Whitters MJ; Young DA
Immunol Res; 2003; 28(2):131-40. PubMed ID: 14610289
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
6. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
7. ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma.
Jovanovic I; Radosavljevic G; Mitrovic M; Juranic VL; McKenzie AN; Arsenijevic N; Jonjic S; Lukic ML
Eur J Immunol; 2011 Jul; 41(7):1902-12. PubMed ID: 21484786
[TBL] [Abstract][Full Text] [Related]
8. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma.
Ma HL; Whitters MJ; Konz RF; Senices M; Young DA; Grusby MJ; Collins M; Dunussi-Joannopoulos K
J Immunol; 2003 Jul; 171(2):608-15. PubMed ID: 12847225
[TBL] [Abstract][Full Text] [Related]
9. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 21: a key player in lymphocyte maturation.
Nutt SL; Brady J; Hayakawa Y; Smyth MJ
Crit Rev Immunol; 2004; 24(4):239-50. PubMed ID: 15588224
[TBL] [Abstract][Full Text] [Related]
11. Activated allogeneic NK cells as suppressors of alloreactive responses.
Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
[TBL] [Abstract][Full Text] [Related]
12. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen.
Vankayalapati R; Klucar P; Wizel B; Weis SE; Samten B; Safi H; Shams H; Barnes PF
J Immunol; 2004 Jan; 172(1):130-7. PubMed ID: 14688318
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation.
Villarino AV; Larkin J; Saris CJ; Caton AJ; Lucas S; Wong T; de Sauvage FJ; Hunter CA
J Immunol; 2005 Jun; 174(12):7684-91. PubMed ID: 15944269
[TBL] [Abstract][Full Text] [Related]
14. Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity.
Wilcox RA; Tamada K; Strome SE; Chen L
J Immunol; 2002 Oct; 169(8):4230-6. PubMed ID: 12370353
[TBL] [Abstract][Full Text] [Related]
15. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
[TBL] [Abstract][Full Text] [Related]
16. IL-21 induces the functional maturation of murine NK cells.
Brady J; Hayakawa Y; Smyth MJ; Nutt SL
J Immunol; 2004 Feb; 172(4):2048-58. PubMed ID: 14764669
[TBL] [Abstract][Full Text] [Related]
17. The innate NK cells, allograft rejection, and a key role for IL-15.
Kroemer A; Xiao X; Degauque N; Edtinger K; Wei H; Demirci G; Li XC
J Immunol; 2008 Jun; 180(12):7818-26. PubMed ID: 18523245
[TBL] [Abstract][Full Text] [Related]
18. Emergence of NK Cell Hyporesponsiveness after Two IL-15 Stimulation Cycles.
Frutoso M; Morisseau S; Tamzalit F; Quéméner A; Meghnem D; Leray I; Jacques Y; Mortier E
J Immunol; 2018 Jul; 201(2):493-506. PubMed ID: 29848756
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
[TBL] [Abstract][Full Text] [Related]
20. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
